GATA-1 and GATA-2 binding to 3′ enhancer of WT1 gene is essential for its transcription in acute leukemia and solid tumor cell lines

Leukemia

Volumn 23, Issue 7, 2009, Pages 1270-1277

  Furuhata, A ^a   Murakami, M ^a   Ito, H ^a   Gao, S ^a   Yoshida, K ^a   Sobue, S ^b   Kikuchi, R ^c   Iwasaki, T ^c   Takagi, A ^a   Kojima, T ^a   Suzuki, M ^d   Abe, A ^d   Naoe, T ^d   Murate, T ^a  

^a NAGOYA UNIVERSITY   (Japan)

^b CHUBU UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR GATA 2; WT1 PROTEIN;

ACUTE LEUKEMIA; ARTICLE; BINDING SITE; CANCER CELL CULTURE; CELL STRAIN HL 60; CLINICAL ARTICLE; CONTROLLED STUDY; ENHANCER REGION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; SOLID TUMOR;

EID: 67650895879     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2009.13     Document Type: Article

References (33)

1. Hewitt SM, Hamada S, McDonnell TJ, Rauscher III FJ, Saunder GF. Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene, WT1. Cancer Res 1995; 55: 5386-5389.
2. Lou XN, Reddy JC, Yeyeti PL, Idris AH, Hosono S, Haber DA et al. The tumor suppressor gene WT1 inhibits ras-mediated transformation. Oncogene 1995; 11: 743-750.
3. Keilholz U, Menssen HD, Gaiger A, Menke A, Oji Y, Oka J et al. Wilms' tumour gene 1 (WT1) in human neoplasia. Leukemia 2005; 19: 13181-13323.
4. Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call KM, Housman DE. Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc Natl Acad Sci USA 1991; 88: 9618-9622.
5. Loeb DM. WT1 influences apoptosis through transcriptional regulation of Bcl-2 family members. Cell Cycle 2006; 5: 1249-1253.
6. Jomgeow T, Oji Y, Tsuji N, Ikeda Y, Ito K, Tsuda A et al. Wilms' tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro. Cancer Sci 2006; 97: 259-270.
7. Ito K, Oji Y, Tatsumi N, Shimizu S, Kanai Y, Nakazawa T et al. Antiapoptotic function of 17AA(+) WT1 (Wilms' tumor gene) isoforms on the intrinsic apoptosis pathway. Oncogene 2006; 25: 4217-4229.
8. Oji Y, Ogawa H, Tamaki H, Oka Y, Tsuboi A, Kim EM et al. Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth. Int J Cancer Res 1999; 90: 194-204.
9. Boublikova L, Kalinova M, Ryan J, Quinn F, O'Marcaigh A, Smith O et al. Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: A wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring. Leukemia 2006; 20: 254-263.
10. Tamaki H, Ogawa H, Ohyashiki K, Ohyashiki JH, Iwama H, Inoue K et al The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes. Leukemia 1999; 13: 393-399.
11. Weisser M, Kern W, Rauhut S, Schoch C, Hiddemann W, Haferlach T et al Prognostic impact of RT-PCR-based quantification of WT1 gene expression during MRD monitoring of acute myeloid leukemia. Leukemia 2005; 19: 1416-1423.
12. Yang L, Han Y, Suarez Saiz F, Minden MD. A tumor suppressor and oncogene: The WT1 story. Leukemia 2007; 21: 868-876.
13. Cohen HT, Bossone SA, Zhu G, McDonald GA, Sukhatme VP. Sp1 is a critical regulator of the Wilms' tumor-1 gene. J Biol Chem 1997; 272: 2901-2913.
14. Fraizer GC, Wu YJ, Hewitt SM, Maity T, Yon CC, Huff V et al. Transcriptional regulation of the human Wilms' tumor gene (WT1): cell type-specific enhancer and promiscuous promoter. J Biol Chem 1994; 269: 8892-8900.
15. Wu Y, Fraizer GC, Saunders GF. GATA-1 transactivates the WT1 hematopoietic specific enhancer. J Biol Chem 1995; 270: 5944-5949.
16. Hosen N, Yanagihara M, Nakazawa T, Kanato K, Nishida S, Asada T et al Identification of a gene element essential for leukemia-specific expression of transgenes. Leukemia 2004; 18: 415-419.
17. Dehbi M, Pelletier J. PAX-8-mediated activation of the wt1 tumor suppressor gene. EMBO J 1996; 15: 4297-4306.
18. Siehl JM, Thiel E, Heufelder K, Snarski E, Schwartz S, Mailander V et al. Possible regulation of Wilms' tumour gene 1 (WT1) expression by the paired box genes PAX2 and PAX8 and by the haematopoietic transcription factor GATA-1 in human acute myeloid leukaemias. Br J Haematol 2003; 123: 235-242.
19. Fraizer GC, Shimamura R, Zhang X, Saunders GF. PAX 8 regulates human WT1 transcription through a novel DNA binding site. J Biol Chem 1997; 272: 30678-30687.
20. Zhang X, Xing G, Fraizer GC, Saunders F. Transactivation of an intronic hematopoietic-specific enhancer of the human Wilms' tumor 1 gene by GATA-1 and c-Myb. J Biol Chem 1997; 2720: 29272-29280.
21. Ohneda K, Yamamoto M. Roles of hematopoietic transcription factors GATA-1 and GATA-2 in the development of red blood cell lineage. Acta Hematol 2002; 108: 237-245.
22. Weiss MJ, Orkin SH. GATA transcription factors: Key regulators of hematopoiesis. Exp Hematol 1995; 23: 99-107.
23. Shimamoto T, Ohyashiki K, Ohyashiki JH, Kawakubo K, Fujimura T, Iwama H et al. The expression pattern of erythrocyte/megakaryocyte-related transcription factor GATA-1 and the stem cell leukemia gene correlates with hematopoietic differentiation and is associated with outcome of acute myeloid leukemia. Blood 1995; 86: 3173-3180.
24. Iwasaki T, Sugisaki C, Nagata K, Takagi A, Kojima T, Ito M et al. Wilms' tumor 1 message and protein expression in bone marrow failure syndrome and acute leukemia. Pathol Int 2007; 57: 645-651.
25. Sobue S, Iwasaki T, Sugisaki S, Nagata K, Kikuchi R, Murakami M et al Quantitative RT-PCR analysis of sphingolipid metabolic enzymes in acute leukemia and myelodysplastic syndromes. Leukemia 2006; 20 2042-2046.
26. Kikuchi R, Murakami M, Sobue S, Iwasaki T, Hagiwara K, Takagi A et al. Ewing's sarcoma fusion protein, EWS/Fli-1 and Fli-1 protein induce PLD2 but not PLD1 gene expression by binding to an ETS domain of 50 promoter. Oncogene 2007; 26: 1802-1810.
27. Ho IC, Vorhees P, Marin N, Oakley BK, Tsai SF, Orkin SH et al. Human GATA-3: A lineage-restricted transcription factor that regulates the expression of the T cell receptor alpha gene. EMBO J 1991; 10: 1187-1192.
28. Ko L, Yamamoto M, Leonard MW, George KM, Ting P, Engel JD. Murine and human T-lymphocyte GATA-3 factors mediate transcription through a cis-regulatory element within the human T-cell receptor delta gene enhancer. Mol Cell Biol 1991; 11: 2778-2784.
29. Tagge EP, Hanson P, Re GG, Othersen Jr HB, Smith CD, Garvin AJ. Paired box gene expression in Wilms' tumor. J Pediatr Surg 1994; 29 134-141.
30. Dressler GR, Douglas EC. Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor. Proc Natl Acad Sci USA 1992; 89: 1179-1183.
31. Hosen N, Sonoda Y, Oji Y, Kimura T, Minamiguchi H, Tamaki H et al. Very low frequencies of human normal CD34+ haematopoietic progenitor cells express the Wilms' tumor gene WT1 at levels similar to those in leukemia cells. Br J Haematol 2002; 116: 409-420.
32. Mouthon MA, Bernard O, Mitjavila MT, Romeo PH, Vainshenker W, Mathieu-Mahul D. Expression of tal-1 and GATA-binding proteins during human hematopoiesis. Blood 1993; 81: 647-655.
33. Maratheftis CI, Bolaraki PE, Voulgarelis M. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes. Am J Hematol 2007; 82: 887-892.